Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2012-01-13

Clinical Trial Update: Safety and Efficacy of Gabapentin in Postherpetic Neuralgia [Phase 3]

View source ↗

Summary

Phase 3 clinical trial evaluating the safety and efficacy of gabapentin for postherpetic neuralgia; results have been posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Gabapentin (Neurontin) (gabapentin)

Snippet

Sponsor: Depomed | Conditions: Neuralgia,Postherpetic | Phase 3 | Status: COMPLETED | Results posted: 2012-01-13